Publikationen, an denen er mitarbeitet CARLOS JUAN LUMBRERAS BERMEJO (29)

2024

  1. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  3. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

  4. Making EHRs Trustable: A Quality Analysis of EHR-Derived Datasets for COVID-19 Research

    Studies in Health Technology and Informatics

  5. Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis

    Medicina Clinica, Vol. 158, Núm. 12, pp. 608-612

2021

  1. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID

    Biomedicines, Vol. 9, Núm. 11

  2. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  3. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  4. Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study

    Liver Transplantation, Vol. 27, Núm. 6, pp. 913-917

  5. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients

    Transplant Infectious Disease, Vol. 23, Núm. 2

  6. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 6, pp. 1209-1216

  7. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12

  8. Soluble fms-like tyrosine kinase-1: A potential early predictor of respiratory failure in COVID-19 patients

    Clinical Chemistry and Laboratory Medicine

  9. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

  2. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389

  3. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain

    EClinicalMedicine, Vol. 23

  4. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Transplantation Reviews, Vol. 34, Núm. 2

  5. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain

    Transplant Infectious Disease, Vol. 22, Núm. 5